X
Dear User,
On May 25, 2018, Regulation (EU) 2016/679 of the European Parliament and of the Council of April 27, 2016 (General Data Protection Regulation) came into force. We encourage you to familiarise yourself with information about the processing of personal data on the PolskieRadio.pl website.
1.The Data Administrator is Polish Radio S.A., based at 77/85 Niepodległości Ave., 00-977, Warsaw.
2.On issues regarding your data, please contact the Data Protection Officer, e-mail: iod@polskieradio.pl, tel. 22 645 34 03.
3.Personal data may be processed for marketing purposes based on consent.
4.Personal data may be shared solely for the purpose of proper implementation of services defined in the privacy policy.
5.Personal data will not be transferred outside the European Economic Area or to an international organisation.
6.Personal data will be stored for 5 years after an account is deactivated, in accordance with the law.
7.You have the right to access your personal data, correct it, to have it moved or deleted, or to limit its processing.
8.You have the right to object to further processing, and in the case of voicing consent to the processing of personal data, you have the right to withdraw your consent. The exercise of the right to withdraw consent does not affect any processing that has already taken place.
9.You have the right to lodge a complaint with the supervisory authority.
10.Polish Radio S.A. declares that no automated decisions are made when personal data is processed, and that profiling is not used.
For more information on this subject, please read our personal data and privacy policy.
I UNDERSTAND
English Section

16 million doses of Johnson & Johnson COVID-19 vaccine for Poland: health minister

04.03.2021 07:50
Poland has ordered 16 million doses of a COVID-19 vaccine developed by US drug maker Johnson & Johnson, Health Minister Adam Niedzielski has said.
Johnson  Johnsons Janssen COVID-19 vaccine.
Johnson & Johnson's Janssen COVID-19 vaccine.Photo: EPA/TIMOTHY D. EASLEY

He added that deliveries should begin next month.

“We expect to receive nearly 16 million doses of this vaccine; that's the amount we have ordered, and shipments should begin arriving in April," he told reporters on Wednesday.

He added that the European Medicines Agency (EMA), the EU’s drug regulator, had also opened a fast-track “rolling review” procedure for a COVID-19 vaccine being developed by American producer Novavax.

Photo: Photo: Hakan Nural/Anadolu Agency/PAP/ABACAPRESS.COM

Officials in Warsaw have announced that domestic biotechnology firm Mabion has struck a deal with the US manufacturer to produce the vaccine in Poland.

The Novavax vaccine has "a realistic prospect of being approved in the second quarter of this year," Niedzielski said.

The European Union, of which Poland is part, has struck deals to secure vaccines from Pfizer-BioNTech, AstraZenecaModernaCureVacSanofi-GSK, and Johnson & Johnson.

The European Medicines Agency is on March 11 expected to issue an opinion on whether to approve Johnson & Johnson’s COVID-19 vaccine under a speedy review.

Johnson & Johnson has said it is ready to start distributing the vaccine across the EU in the second quarter of 2021.

The EU drug regulator said on February 12 it had launched a real-time review of CureVac's COVID-19 vaccine to speed up potential approvals.

The regulator said its human medicines committee would review data from ongoing trials of the German biopharmaceutical firm's vaccine until there is enough clinical data for approval.

Photo: Photo: PAP/DPA/Frank Hoermann/SVEN SIMON

Meanwhile, Polish President Andrzej Duda has talked to China’s leader Xi Jinping about a possible purchase of a Chinese COVID-19 vaccine, an aide said on Monday.

(gs/pk)

Source: PAP